Mark W. Begor - 28 Jul 2025 Form 4 Insider Report for EQUIFAX INC (EFX)

Role
CEO, Director
Signature
/s/Lisa Stockard as Attorney-in-Fact
Issuer symbol
EFX
Transactions as of
28 Jul 2025
Net transactions value
-$6,313,351
Form type
4
Filing time
30 Jul 2025, 16:20:27 UTC
Previous filing
23 May 2025
Next filing
29 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Begor Mark W CEO, Director 1550 PEACHTREE STREET, N.W., ATLANTA /s/Lisa Stockard as Attorney-in-Fact 30 Jul 2025 0001335111

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EFX Common Stock Options Exercise $5,352,662 +27,960 +17% $191.44 191,136 28 Jul 2025 Direct
transaction EFX Common Stock Sale $89,161 -364 -0.19% $244.95 190,772 28 Jul 2025 Direct F1, F2, F3
transaction EFX Common Stock Sale $202,684 -831 -0.44% $243.90 189,941 28 Jul 2025 Direct F1, F3, F4
transaction EFX Common Stock Sale $2,304,935 -9,497 -5% $242.70 180,444 28 Jul 2025 Direct F1, F3, F5
transaction EFX Common Stock Sale $4,288,620 -17,731 -9.8% $241.87 162,713 28 Jul 2025 Direct F1, F3, F6
transaction EFX Common Stock Sale $4,780,614 -19,841 -12% $240.95 142,872 28 Jul 2025 Direct F1, F3, F7
holding EFX Common Stock 10,500 28 Jul 2025 2-yr 2025 GRAT
holding EFX Common Stock 9,525 28 Jul 2025 2-yr Feb 2024 GRAT
holding EFX Common Stock 11,380 28 Jul 2025 2-yr Jul 2024 GRAT
holding EFX Common Stock 43,431 28 Jul 2025 2-yr Jun 2025 GRAT
holding EFX Common Stock 12,333 28 Jul 2025 2-yr May 2025 GRAT
holding EFX Common Stock 16,287 28 Jul 2025 3-yr Jul 2024 GRAT

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EFX Stock Option/Right to Buy Options Exercise $0 -27,960 -50% $0.000000 27,959 28 Jul 2025 Common Stock 27,960 $191.44 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/14/2024.
F2 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $244.72 to $245.33, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
F3 Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 199 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan.
F4 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $243.47 to $244.44, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
F5 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $242.41 to $243.17, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
F6 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $241.41 to $242.40, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
F7 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $240.40 to $241.39, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
F8 The option vested in three equal annual increments beginning 2/21/2021.